Study of Bone Disease in Older HIV-infected Adults
A Pilot Study on the Immunopathogenesis of Bone Disease in Older HIV-infected Adults
Sponsor: Merck Sharp & Dohme LLC
A observational or N/A phase clinical study on Aging and HIV Infection, this trial is completed. The trial is conducted by Merck Sharp & Dohme LLC and has accumulated 11 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2022 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Jun 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Dec 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Merck Sharp & Dohme LLC
- Rush University Medical Center
- Ruth M. Rothstein CORE Center
For direct contact, visit the study record on ClinicalTrials.gov .